| abstract |
The present invention relates to a bilayer tablet composition comprising candesartan or pharmaceutically acceptable forms, amlodipine or a pharmaceutically acceptable salt thereof, and hydrochlorothiazide, wherein amlodipine and hydrochlorothiazide, wherein candesartan or pharmaceutically acceptable salt is present in a separate layer with optimized ratio range for polyethylene glycol and disintegrant is between 1:3 to 1:5. |